AstraZeneca Got Its Vaccine Right. The Rollout Has Been a Mess.

The drugmaker has tangled with U.S. government over data about the shot’s efficacy. In Europe, production delays have drawn criticism from politicians, and the company has gotten caught up in diplomatic tensions over supplies.

The Wall Street Journal | Dirección, Operaciones | Farmacia |

Leer noticia completa en el medio original
Spanish